At close: 4:00:01 PM EST
After hours: 4:33:58 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
1,000.0000
7,600.0000
1,900.0000
Cost of Revenue
100.0000
--
100.0000
200.0000
--
Gross Profit
900.0000
--
900.0000
7,400.0000
1,900.0000
Operating Expense
32,772.0000
37,869.0000
32,850.0000
26,994.0000
18,882.0000
Operating Income
-32,772.0000
-37,869.0000
-31,950.0000
-19,594.0000
-16,982.0000
Net Non Operating Interest Income Expense
492.0000
525.0000
317.0000
6.0000
26.0000
Other Income Expense
4,949.0000
4.0000
-9,668.0000
-1,348.0000
182.0000
Pretax Income
-32,280.0000
-37,340.0000
-41,301.0000
-20,936.0000
-16,774.0000
Tax Provision
--
--
--
-237.0000
-17.0000
Net Income Common Stockholders
-32,280.0000
-37,340.0000
-41,301.0000
-20,699.0000
-16,835.0000
Diluted NI Available to Com Stockholders
-32,280.0000
-37,340.0000
-41,301.0000
-20,699.0000
-16,835.0000
Basic EPS
-0.67
-1.34
-2.13
-1.34
-2.11
Diluted EPS
-0.67
-1.34
-2.13
-1.34
-2.11
Basic Average Shares
50,406.6380
27,777.1110
19,395.7090
15,481.1130
7,977.1040
Diluted Average Shares
50,406.6380
27,777.1110
19,395.7090
15,481.1130
7,977.1040
Total Operating Income as Reported
-32,772.0000
-37,869.0000
-41,950.0000
-25,294.0000
-16,982.0000
Total Expenses
32,772.0000
37,869.0000
32,950.0000
27,194.0000
18,882.0000
Net Income from Continuing & Discontinued Operation
-32,280.0000
-37,340.0000
-41,301.0000
-20,699.0000
-16,757.0000
Normalized Income
-32,280.0000
-37,344.0000
-31,633.0000
-19,366.2596
-16,938.8180
Interest Income
492.0000
525.0000
317.0000
6.0000
26.0000
Net Interest Income
492.0000
525.0000
317.0000
6.0000
26.0000
EBIT
-32,772.0000
-37,869.0000
-31,950.0000
-19,594.0000
-16,982.0000
EBITDA
-32,772.0000
-37,869.0000
-31,950.0000
-19,594.0000
-16,982.0000
Reconciled Cost of Revenue
100.0000
--
100.0000
200.0000
--
Reconciled Depreciation
--
--
--
--
282.0000
Net Income from Continuing Operation Net Minority Interest
-32,280.0000
-37,340.0000
-41,301.0000
-20,699.0000
-16,757.0000
Total Unusual Items Excluding Goodwill
--
4.0000
-9,668.0000
-1,348.0000
182.0000
Total Unusual Items
--
4.0000
-9,668.0000
-1,348.0000
182.0000
Normalized EBITDA
-32,772.0000
-37,873.0000
-22,282.0000
-18,246.0000
-17,164.0000
Tax Rate for Calcs
--
--
--
0.0000
0.0000
Tax Effect of Unusual Items
--
--
--
-15.2596
0.1820
12/31/2020 - 3/12/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1244.HK 3D MEDICINES
3.120
-14.29%
ATOS Atossa Therapeutics, Inc.
1.0700
-4.46%
GALT Galectin Therapeutics Inc.
2.3100
+9.48%
GLSI Greenwich LifeSciences, Inc.
12.90
-4.52%
ICU SeaStar Medical Holding Corporation
1.8400
-7.54%
EYEN Eyenovia, Inc.
0.0816
-2.28%
CLRB Cellectar Biosciences, Inc.
0.2577
-0.88%
AVXL Anavex Life Sciences Corp.
9.18
+8.51%
BCTX BriaCell Therapeutics Corp.
0.6081
-7.86%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.3000
-11.88%